Atlas Trials

Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM

Clinical trial NCT03961971 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03961971
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Glioblastoma Multiforme
Start date
2020-02-18
Primary completion
2022-11-16
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.